Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Mar, 4 2026
Sep, 1 2025
Dec, 20 2025
Oct, 19 2025
Aug, 11 2025